in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (4 days ago)
RT @barryhardy: Do want an exciting career journey for 2019? Help advance the development and application of #Safety #Assessment Products d…
Douglas Connect (2 weeks ago)
Some of our most powerful modern pharmaceuticals come from nature. However, we are still nowhere near making full u… https://t.co/xPbh8qgsFB
Douglas Connect (2 weeks ago)
RT @barryhardy: Collaborative Developments on new methods #Safety #assessment #toxicology #risk #healthcare #environment at the National Co…
Douglas Connect (3 weeks ago)
We are looking for a strategic marketing leader to join the DC team - looking for a strong and dedicated knowledge… https://t.co/RDtLzKs4bL
Douglas Connect (4 weeks ago)
Register now to the hands-on training on #InVitro flow systems & #FAIR data integration for #SafetyAssessment Early… https://t.co/Hhu0kmE3U2

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com